MINAPHARM PHARMACEUTICALS |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.3 EGP | 0.00% |
|
0.00% | -8.00% |
Business Summary
Sales per Business
| EGP in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Bio-production
43.0
%
| 1,106 | 36.8 % | 1,555 | 43.0 % | +40.61% |
Other Services
33.7
%
| 1,343 | 44.7 % | 1,220 | 33.7 % | -9.15% |
Medicine Production
21.6
%
| 499 | 16.6 % | 783 | 21.6 % | +56.91% |
Commercial
1.7
%
| 58 | 1.9 % | 63 | 1.7 % | +8.63% |
Sales per region
| EGP in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Egypt
64.0
%
| 2,122 | 70.6 % | 2,318 | 64.0 % | +9.22% |
International
36.0
%
| 883 | 29.4 % | 1,303 | 36.0 % | +47.50% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Executive Officer | - | - | |
Rafiq Raymond
DFI | Director of Finance/CFO | - | - |
| Investor Relations Contact | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chief Executive Officer | - | - | |
| Director/Board Member | - | - | |
| Chief Executive Officer | - | - | |
| Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 12,293,440 | 3,355,812 ( 27.30 %) | 0 | 27.30 % |
Company contact information
Minapharm Pharmaceuticals
2T Takseem Asmaa Fahmy Street Asmaa Fahmy
11757, Cairo
+202 2414 3170
http://www.minapharm.com
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| -8.00% | 4.73Cr | |
| +21.28% | 4.44TCr | |
| +24.60% | 2.3TCr | |
| +18.40% | 1.51TCr | |
| +12.87% | 1.31TCr | |
| +44.67% | 1.19TCr | |
| -8.33% | 698.92Cr | |
| -0.05% | 678.76Cr | |
| -8.87% | 572.55Cr | |
| +12.22% | 551.54Cr |
- Stock Market
- Equities
- MIPH Stock
- Company MINAPHARM Pharmaceuticals